Xconomy’s Digital Events →
Derrick Gingery is a senior writer for the Pink Sheet.
Pfizer Inc. CEO Albert Bourla said he doesn’t worry about political pressure to bring potentially the first coronavirus vaccine to market, but can’t escape feeling the weight of the world on... Read more »
Expedited programs usually shorten a US Food and Drug Administration new drug application assessment, but on average, maybe not as much as their reputation would suggest.
A Government Accountability Office (GAO) ... Read more »
From Our Editors · Special Report
The AI, Big Data, and R&D Boom
Sponsored · Webinar
How Functional Cell-based Assays Support Clinical Programs Managing Proinflammatory Cytokines Associated with High Mortality
Sponsored · Whitepaper
What the most successful life sciences fundraising pitch decks all have in common
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.